245 related articles for article (PubMed ID: 26864319)
1. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
Semenov AG; Katrukha AG
Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
[TBL] [Abstract][Full Text] [Related]
2. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge?
Lippi G; Sanchis-Gomar F
Int J Cardiol; 2016 Sep; 219():111-4. PubMed ID: 27317994
[TBL] [Abstract][Full Text] [Related]
3. Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure.
Feygina EE; Artemieva MM; Postnikov AB; Tamm NN; Bloshchitsyna MN; Medvedeva NA; Katrukha AG; Semenov AG
Clin Chem; 2019 Oct; 65(10):1239-1247. PubMed ID: 31307994
[TBL] [Abstract][Full Text] [Related]
4. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
[TBL] [Abstract][Full Text] [Related]
5. Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Nougué H; Pezel T; Picard F; Sadoune M; Arrigo M; Beauvais F; Launay JM; Cohen-Solal A; Vodovar N; Logeart D
Eur J Heart Fail; 2019 May; 21(5):598-605. PubMed ID: 30520545
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between natriuretic peptides and neprilysin pathways: the clinical simplification against the complexity of biological systems].
Di Tano G; Clerico A
G Ital Cardiol (Rome); 2017 Feb; 18(2):95-100. PubMed ID: 28398362
[TBL] [Abstract][Full Text] [Related]
7. Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy.
Maisel AS; Daniels LB; Anand IS; McCullough PA; Chow SL
Postgrad Med; 2018 Apr; 130(3):299-307. PubMed ID: 29596012
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
Chrysant SG
J Am Soc Hypertens; 2017 Jul; 11(7):461-468. PubMed ID: 28652105
[TBL] [Abstract][Full Text] [Related]
9. BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era.
Sbolli M; deFilippi C
Curr Cardiol Rep; 2020 Sep; 22(11):150. PubMed ID: 32951154
[TBL] [Abstract][Full Text] [Related]
10. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood.
Tamm NN; Seferian KR; Semenov AG; Mukharyamova KS; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
Clin Chem; 2008 Sep; 54(9):1511-8. PubMed ID: 18606632
[TBL] [Abstract][Full Text] [Related]
11. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.
Seferian KR; Tamm NN; Semenov AG; Mukharyamova KS; Tolstaya AA; Koshkina EV; Kara AN; Krasnoselsky MI; Apple FS; Esakova TV; Filatov VL; Katrukha AG
Clin Chem; 2007 May; 53(5):866-73. PubMed ID: 17384012
[TBL] [Abstract][Full Text] [Related]
12. Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Jhund PS; Claggett B; Packer M; Zile MR; Voors AA; Pieske B; Lefkowitz M; Shi V; Bransford T; McMurray JJ; Solomon SD
Eur J Heart Fail; 2014 Jun; 16(6):671-7. PubMed ID: 24692284
[TBL] [Abstract][Full Text] [Related]
13. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
Semenov AG; Feygina EE
Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of B-type natriuretic peptides in the era of angiotensin receptor-neprilysin inhibitors.
Bettencourt P; Fonseca C; Franco F; Andrade A; Brito D
Rev Port Cardiol; 2017 Dec; 36(12):881-884. PubMed ID: 29225105
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study.
Myhre PL; Prescott MF; Claggett B; Felker GM; Butler J; Piña IL; Maisel AS; Williamson KM; Ward JH; Solomon SD; Januzzi JL
Clin Chem; 2022 Nov; 68(11):1391-1398. PubMed ID: 36103292
[TBL] [Abstract][Full Text] [Related]
16. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
Ibrahim NE; McCarthy CP; Shrestha S; Gaggin HK; Mukai R; Szymonifka J; Apple FS; Burnett JC; Iyer S; Januzzi JL
J Am Coll Cardiol; 2019 Mar; 73(11):1273-1284. PubMed ID: 30898202
[TBL] [Abstract][Full Text] [Related]
17. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
[TBL] [Abstract][Full Text] [Related]
18. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.
Mann DL; Greene SJ; Givertz MM; Vader JM; Starling RC; Ambrosy AP; Shah P; McNulty SE; Mahr C; Gupta D; Redfield MM; Lala A; Lewis GD; Mohammed SF; Gilotra NA; DeVore AD; Gorodeski EZ; Desvigne-Nickens P; Hernandez AF; Braunwald E;
JACC Heart Fail; 2020 Oct; 8(10):789-799. PubMed ID: 32641226
[TBL] [Abstract][Full Text] [Related]
19. Human pro-B-type natriuretic peptide is processed in the circulation in a rat model.
Semenov AG; Seferian KR; Tamm NN; Artem'eva MM; Postnikov AB; Bereznikova AV; Kara AN; Medvedeva NA; Katrukha AG
Clin Chem; 2011 Jun; 57(6):883-90. PubMed ID: 21474642
[TBL] [Abstract][Full Text] [Related]
20. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Jhund PS; Claggett BL; Voors AA; Zile MR; Packer M; Pieske BM; Kraigher-Krainer E; Shah AM; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
Circ Heart Fail; 2014 Nov; 7(6):953-9. PubMed ID: 25277997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
